Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Treatment

Our milestones: How a combination of events led to a cure for a rare cancer

We go back to the 1950s to find out how one of our scientists helped transform the outlook for women with a rare cancer called choriocarcinoma.

3 in 4 Cancer Drugs Fund treatments now available on NHS

Three quarters of the drugs previously only accessible to patients via the Cancer Drugs Fund (CDF) are now approved on the NHS.

“What’s happening to make treatments better and less horrible?”– Alyssa’s story

When she was four, Alyssa was diagnosed with cancer. Here, she and her mom Angela tell her story.

IMRT: bending radiotherapy beams to spare healthy cells

Part three of our new blog series on radiotherapy explores a type of radiotherapy treatment called IMRT. We cover what it is, how it’s already improved the lives of many...

‘Nothing to lose and everything to gain’ – Alfred’s story

Read Alfred's story of joining the STAMPEDE clinical trial. His is one of the many stories featured in our 2016/17 Annual Review.

Proton beam therapy is arriving in the UK: what does that mean for patients?

In part 2 of our new radiotherapy series, we discuss proton beam therapy. What can and can’t it offer? And what does its arrival in the UK mean for patients?

An introduction to radiotherapy: what is it, how does it work, and what’s it for?

Today we’re launching a brand new series on radiotherapy. In this instalment, find out about the treatment's fascinating history and how it works.

8 new challenges between us and beating cancer

We launch phase 2 of our Grand Challenge with 8 of the biggest questions in cancer research.

News digest – smoking rates falling, aspirin risks, breast cancer drug U-turn and… ‘tanning drugs’?

Smoking rates falling, aspirin has risks as well as benefits, breast cancer drug U-turn in England and… what's behind the talk of ‘tanning drugs’? Here's our weekly news...

Breast cancer drug approved for NHS England

The drug trastuzumab emtansine (Kadcyla) will soon be routinely available for patients in England with an advanced type of breast cancer.

Pages